STOCKNO.DE
Institutional ownership intelligence

PMN Institutional Ownership

ProMIS Neurosciences Inc.

Latest stored close $9.12 as of Oct 7, 2026 View live quote ↗

☆ Add to watchlist
STOCKNODE Outlook

Sell

30/100 1 tracked · 1 comparable
Latest filing Aug 13, 2026
Positive breadth 0 positive · 1 negative
Recent close $9.12
Research confidence Limited
Institutional Research 20/100 · 0 accumulating · 1 reducing / exited
Ownership history

Reported ownership % history

Latest filing Aug 13, 2026

See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.

Locked preview
Unlock the reported ownership timeline Unlock full research
Accumulating0
Newly reported0
Reducing / exited 1
52-week position —
Institutional Intelligence

Why STOCKNODE says Sell

What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.

5 evidence layers available
STOCKNODE Outlook
Sell 30/100
Confidence:Limited
Why this signal
  • 0 tracked institutions accumulating versus 1 reducing/exited.
STOCKNODE Outlook is a quantitative research signal based on reported public data, not personalized investment advice.
Institutional
20/100
Insiders
59/100
Fundamentals
32/100
Events
50/100

Cross-institution positioning

Aug 13, 2026

Strong institutional reduction. 1 reducing across 1 comparable institution.

Source: Schedule 13 research

Insider filing activity

Oct 5, 2026

Over the last 90 days, SEC-coded non-derivative P/S activity includes 1 purchase by 1 reporting owner and 0 sales by 0 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.

Source: SEC Forms 3/4/5

Material company events

Aug 13, 2026

2 non-amendment material events in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.

Source: SEC 8-K / securities filing metadata

SEC fundamentals

Aug 13, 2026

Net income -15.9% YoY; Free cash flow -83.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.

Source: SEC Company Facts

Price context

Sep 15, 2026

Recent close is 31% through its reported 52-week range; +22.8% over one year.

Source: Stored historical price series
Latest filing decision brief Investor / Pro

Research the latest Schedule 13G amendment from Wellington Management Group.

Filed Aug 13, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.

Premium research values are withheld until unlocked.

Supporting institutional evidence

Institutional Evidence

The research summary above gives the current read. This section shows the dated holder-level evidence behind it.

Latest reported position changes

Investor / Pro detail

See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.

Newest filing Aug 13, 2026
Wellington Management Group Filed Aug 13, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis. No premium position values are sent in this locked preview.
Unlock full research

Reported direction breadth by as-of date

Locked preview

Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.

Unlock actual accumulation vs. reduction breadth across reported position dates. View plans

Institution comparison

Investor / Pro detail

Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.

Wellington Management Group Filed Aug 13, 2026
Unlock the evidence behind the score

Know who changed position, by how much, and when the SEC learned about it.

Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.

✓ Actual share and ownership changes ✓ Position as-of date vs. SEC filed date ✓ Deterministic direction basis ✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5

Insider activity

Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.

Latest filing Oct 6, 2026
30-day purchases00 reporting owner(s)
30-day sales00 reporting owner(s)
90-day purchase breadth1
90-day sale breadth0
View recent insider filing evidence
DateReporting ownerCodeSecuritySharesPriceOwnershipFiled
Oct 5, 2026 Rubino Ivana AGrant, award, or other acquisition · derivative Option (right to buy) 80.0K $0.00 Direct Oct 6, 2026
Aug 5, 2026 Kaplan Johanne POpen-market or private purchase Common Shares 2.3K $13.30 Direct Aug 7, 2026
May 20, 2026 WYMAN WILLIAM W AGrant, award, or other acquisition · derivative Option (right to buy) 11.0K $0.00 Direct May 22, 2026
May 20, 2026 WYMAN WILLIAM W AGrant, award, or other acquisition · derivative Option (right to buy) 5.5K $0.00 Direct May 22, 2026
May 20, 2026 Williams Eugene AGrant, award, or other acquisition · derivative Option (right to buy) 11.0K $0.00 Direct May 22, 2026
May 20, 2026 Williams Eugene AGrant, award, or other acquisition · derivative Option (right to buy) 5.5K $0.00 Direct May 22, 2026
May 20, 2026 Warma Neil K AGrant, award, or other acquisition · derivative Option (right to buy) 160.0K $0.00 Direct May 22, 2026
May 20, 2026 Shafmaster Madge K. AGrant, award, or other acquisition · derivative Option (right to buy) 11.0K $0.00 Direct May 22, 2026
May 20, 2026 Shafmaster Madge K. AGrant, award, or other acquisition · derivative Option (right to buy) 5.5K $0.00 Direct May 22, 2026
May 20, 2026 Cashman Neil AGrant, award, or other acquisition · derivative Option (right to buy) 50.0K $0.00 Direct May 22, 2026
May 20, 2026 Milbury Max A. AGrant, award, or other acquisition · derivative Option (right to buy) 18.2K $0.00 Direct May 22, 2026
May 20, 2026 Mandel-Brehm Josh AGrant, award, or other acquisition · derivative Option (right to buy) 11.0K $0.00 Direct May 22, 2026
May 20, 2026 Mandel-Brehm Josh AGrant, award, or other acquisition · derivative Option (right to buy) 5.5K $0.00 Direct May 22, 2026
May 20, 2026 Kaplan Johanne AGrant, award, or other acquisition · derivative Option (right to buy) 50.0K $0.00 Direct May 22, 2026
May 20, 2026 Alex Slanix Paul AGrant, award, or other acquisition · derivative Option (right to buy) 11.0K $0.00 Direct May 22, 2026
May 20, 2026 Alex Slanix Paul AGrant, award, or other acquisition · derivative Option (right to buy) 5.5K $0.00 Direct May 22, 2026
Apr 22, 2026 Kirwin Patrick D. POpen-market or private purchase Common Shares 4.0K $11.33 Indirect Apr 23, 2026
SEC company-event context

Material company events

Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.

Latest filing Aug 13, 2026
30-day material events0
90-day capital-related0
90-day equity-related0
90-day debt-related0
View recent company-event filing evidence
FiledForm8-K item(s)ClassificationCapital contextSEC
Aug 13, 2026 8-K 2.02, 9.01 Results of operations / financial condition; Financial statements / exhibits — Filing
Jul 28, 2026 8-K 7.01, 8.01, 9.01 Regulation FD disclosure; Other event; Financial statements / exhibits — Filing
May 29, 2026 S-8 — Employee-plan securities registration Equity Filing
May 20, 2026 8-K 5.02, 5.07, 9.01 Director or executive change; Shareholder vote results; Financial statements / exhibits — Filing
May 12, 2026 8-K 2.02, 9.01 Results of operations / financial condition; Financial statements / exhibits — Filing
Mar 25, 2026 S-3 — Shelf securities registration Capital-related Filing
Mar 25, 2026 8-K 2.02, 9.01 Results of operations / financial condition; Financial statements / exhibits — Filing
Mar 18, 2026 S-3 — Shelf securities registration Capital-related Filing
Jan 30, 2026 8-K 1.01, 3.02, 8.01, 9.01 Material definitive agreement; Unregistered sale of equity securities; Other event; Financial statements / exhibits Equity Filing
Dec 16, 2025 8-K 8.01 Other event — Filing
Nov 24, 2025 8-K 5.03, 8.01, 9.01 Charter or bylaw change; Other event; Financial statements / exhibits — Filing
Nov 19, 2025 8-K 5.07 Shareholder vote results — Filing
SEC-reported company fundamentals

Fundamentals

Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.

Latest filing used Aug 13, 2026
Operating income $-12.3M Q2 2026 -20.4% YoY 10-Q filed Aug 13, 2026
Net income $-11.7M Q2 2026 -15.9% YoY 10-Q filed Aug 13, 2026
Diluted EPS $-1.28 Q2 2026 +82.4% YoY 10-Q filed Aug 13, 2026
Operating cash flow $-22.8M YTD through Jun 30, 2026 -159.3% YoY 10-Q filed Aug 13, 2026
Free cash flow $-17.0M FY 2023 -83.0% YoY 10-K filed Apr 1, 2024
Cash & equivalents $53.4M As of Jun 30, 2026 +1,084.7% YoY 10-Q filed Aug 13, 2026
Assets $56.7M As of Jun 30, 2026 +496.2% YoY 10-Q filed Aug 13, 2026
Liabilities $7.3M As of Jun 30, 2026 -26.3% YoY 10-Q filed Aug 13, 2026
Stockholders’ equity $49.4M As of Jun 30, 2026 +13,012.1% YoY 10-Q filed Aug 13, 2026
Shares outstanding 9.0M As of Aug 13, 2026 -82.7% YoY 10-Q filed Aug 13, 2026
Current market context

Price performance

Dated price context from the historical market series already collected for this security.

As of Sep 15, 2026
Recent stored close $12.89 View live quote ↗
52-week low $6.27 Nov 28, 2025
52-week high $27.40 Mar 5, 2026
Below 52-week high 53.0%
Split-adjusted 52-week range · 1 split in this window

Historical prices and the 52-week high/low are normalized to the current share basis so prices before and after a stock split remain directly comparable.

  • Nov 28, 2025: 1-for-25 reverse split.
A stock split mechanically changes the per-share price and share count; it does not by itself represent an investment gain/loss or a change in the company's underlying value.
1W return +2.9%
1M return -13.3%
3M return +28.3%
6M return -29.0%
YTD return +88.7%
1Y return +22.8%
30-day volatility 71.9%
90-day volatility 86.4%
1Y max drawdown -63.2%

Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.

How to read Schedule 13 ownership changes

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.

Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.

Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.

Beneficial ownership filing history

Showing 3 of 3 filing(s)
View beneficial ownership filing evidence
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
Wellington Management Group CIK0000902219 Jun 30, 2026 observed Aug 13, 2026 filed · 44d Schedule 13G amendment Reported reduction 696.4K -8.3M 7.80% -2.20 pts $13.16 $14.79 $9.12
Wellington Management Group CIK0000902219 Mar 31, 2026 quarter end May 15, 2026 filed Form 13F quarter-end evidence Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. 696.4K $9.12
Wellington Management Group CIK0000902219 Mar 31, 2026 observed May 15, 2026 filed · 45d Initial Schedule 13G Initial Schedule 13G 9.0M 10.00% $12.70 $10.39 $9.12
Explore more institutional activity

Related research

Compare PMN with other securities showing similar institutional activity or recent accumulation across several tracked institutions.